Possibility for neurogenesis in substantia nigra of parkinsonian brain

Annals of Neurology

Volumn 58, Issue 1, 2005, Pages 31-40

  Yoshimi, Kenji ^a   Ren, Yong Ri ^b   Seki, Tatsunori ^a,b   Yamada, Masanori ^a   Ooizumi, Hideki ^b   Onodera, Masafumi ^c   Saito, Yuko ^d   Murayama, Shigeo ^d   Okano, Hideyuki ^e   Mizuno, Yoshikuni ^a,b   Mochizuki, Hideki ^a,b  

^a JUNTENDO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^e KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ANTIDEPRESSANT AGENT; GREEN FLUORESCENT PROTEIN; POLYSIALIC ACID; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CELL DIFFERENTIATION; CELL LABELING; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; FEMALE; HIPPOCAMPUS; HUMAN; IMMUNOREACTIVITY; MALE; MOUSE; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PARKINSON DISEASE; PRIMATE; PRIORITY JOURNAL; RAT; RETICULAR FORMATION; RETROVIRUS; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; ANIMALS; CELL DIFFERENTIATION; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MACACA; MALE; MICE; MIDDLE AGED; NEURONS; PARKINSONIAN DISORDERS; RATS; SIALIC ACIDS; STEM CELLS; SUBSTANTIA NIGRA; TRANSDUCTION, GENETIC;

EID: 21844454467     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20506     Document Type: Article

References (45)

1. Malberg JE, Eisch AJ, Nestler EJ, Duman RS. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000;20:9104-9110.
2. Banasr M, Hery M, Brezun JM, Daszuta A. Serotonin mediates oestrogen stimulation of cell proliferation in the adult dentate gyrus. Eur J Neurosci 2001;14:1417-1424.
3. Santarelli L, Saxe M, Gross C, et al. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 2003;301:805-809.
4. Armstrong RJ, Barker RA. Neurodegeneration: a failure of neuroregeneration? Lancet 2001;358:1174-1176.
5. Curtis MA, Penney EB, Pearson AG, et al. Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain. Proc Natl Acad Sci U S A 2003;100:9023-9027.
6. Mikkonen M, Soininen H, Tapiola T, et al. Hippocampal plasticity in Alzheimer's disease: changes in highly polysialylated NCAM immunoreactivity in the hippocampal formation. Eur J Neurosci 1999;11:1754-1764.
7. Jin K, Peel AL, Mao XO, et al. Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci U S A 2004;101:343-347.
8. Hirsch EC, Hunot S, Faucheux B, et al. Dopaminergic neurons degenerate by apoptosis in Parkinson's disease. Mov Disord 1999;14:383-385.
9. Olanow CW, Goetz CG, Kordower JH, et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003;54:403-414.
10. Kay JN, Blum M. Differential response of ventral midbrain and striatal progenitor cells to lesions of the nigrostriatal dopaminergic projection. Dev Neurosci 2000;22:56-67.
11. Lie DC, Dziewczapolski G, Willhoite AR, et al. The adult substantia nigra contains progenitor cells with neurogenic potential. J Neurosci 2002;22:6639-6649.
12. Zhao M, Momma S, Delfani K, et al. Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci U S A 2003;100:7925-7930.
13. Frielingsdorf H, Schwarz K, Brundin P, Mohapel P. No evidence for new dopaminergic neurons in the adult mammalian substantia nigra. Proc Natl Acad Sci U S A 2004;101:10177-10182.
14. Nakatomi H, Kuriu T, Okabe S, et al. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 2002;110:429-441.
15. Zhu DY, Lau L, Liu SH, et al. Activation of cAMP-response-element-binding protein (CREB) after focal cerebral ischemia stimulates neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci U S A 2004;101:9453-9457.
16. Kawai T, Takagi N, Miyake-Takagi K, et al. Characterization of BrdU-positive neurons induced by transient global ischemia in adult hippocampus. J Cereb Blood Flow Metab 2004;24:548-555.
17. Rakic P. Adult neurogenesis in mammals: an identity crisis. J Neurosci 2002;22:614-618.
18. Gould E, Gross CG. Neurogenesis in adult mammals: some progress and problems. J Neurosci 2002;22:619-623.
19. Suzuki SO, Goldman JE. Multiple cell populations in the early postnatal subventricular zone cake distinct migratory pathways: a dynamic study of glial and neuronal progenitor migration. J Neurosci 2003;23:4240-4250.
20. Kaneko S, Onodera M, Fujiki Y, et al. Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice. Hum Gene Ther 2001;12:35-44.
21. Suzuki A, Obi K, Urabe T, et al. Feasibility of ex vivo gene therapy for neurological disorders using the new retroviral vector GCDNsap packaged in the vesicular stomatitis virus G protein. J Neurochem 2002;82:953-960.
22. Yamada M, Onodera M, Mizuno Y, Mochizuki H. Neurogenesis in olfactory bulb identified by retroviral labeling in normal and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-treated adult mice. Neuroscience 2004;124:173-181.
23. Tanaka R, Yamashiro K, Mochizuki H, et al. Neurogenesis after transient global ischemia in the adult hippocampus visualized by improved retroviral vector. Stroke 2004;35:1454-1459.
24. Seki T, Arai Y. Highly polysialylated neural cell adhesion molecule (NCAM-H) is expressed by newly generated granule cells in the dencate gyrus of the adulc rat. J Neurosci 1993;13:2351-2358.
25. Fukuda S, Kato F, Tozuka Y, et al. Two distinct subpopulations of nestin-positive cells in adult mouse dentate gyrus. J Neurosci 2003;23:9357-9366.
26. Furuya T, Hayakawa H, Yamada M, et al. Caspase-11 mediates inflammatory dopaminergic cell death in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J Neurosci 2004;24:1865-1872.
27. Przedborski S, Jackson-Lewis V, Naini AB, et al. The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 2001;76:1265-1274.
28. Altar CA, Heikkila RE, Manzino L, Marien MR. 1-Methyl-4-phenylpyridine (MPP+): regional dopamine neuron uptake, toxicity, and novel rotational behavior following dopamine receptor proliferation. Eur J Pharmacol 1986;131:199-209.
29. Imai H, Nakamura T, Endo K, Narabayashi H. Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP): behavior and histology. Brain Res 1988;474:327-332.
30. Mochizuki H, Imai H, Endo K, et al. Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys. Neurosci Lett 1994;168:251-253.
31. Ito D, Imai Y, Ohsawa K, et al. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res Mol Brain Res 1998;57:1-9.
32. Dawson MR, Levine JM, Reynolds R. NG2-expressing cells in the central nervous system: are they oligodendroglial progenitors? J Neurosci Res 2000;61:471-479.
33. Cammer W, Zhang H. Localization of Pi class glutathione-S-transferase in the forebrains of neonatal and young rats: evidence for separation of astrocytic and oligodendrocytic lineages. J Comp Neurol 1992;321:40-45.
34. Yoshimi K, Iwata N, Takeda M, et al. Ischaemia-induced change in clathrin preceding delayed neuronal death. Neuroreport 1995;6:453-456.
35. Nomura T, Yabe T, Rosenthal ES, Krzan M, Schwartz JP. PSA-NCAM distinguishes reactive astrocytes in 6-OHDA-lesioned substantia nigra from those in the striatal terminal fields. J Neurosci Res 2000;6:588-596.
36. Kawano H, Ohyama K, Kawamura K, Nagatsu I. Migration of dopaminergic neurons in the embryonic mesencephalon of mice. Brain Res Dev Brain Res 1995;86:101-113.
37. Hokfelt-T, Martensson-R, Bjorklund-A, et al. Distributional maps of tyrosine-hydroxylase-immunoreactive neurons in the rat brain. Handbook of chemical neuroanatomy. Vol 2. New York: Elsevier, 1984:277.
38. Alvarez-Buylla A, Garcia-Verdugo JM. Neurogenesis in adult subventricular zone. J Neurosci 2002;22:629-634.
39. Belachew S, Chittajallu R, Aguirre AA, et al. Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. J Cell Biol 2003;161:169-186.
40. Yokoyama A, Yang L, Itoh S, et al. Microglia, a potential source of neurons, astrocytes, and oligodendrocytes. Glia 2004;45:96-104.
41. Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 1995;4:257-269.
42. Ho A, Blum M. Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated scriatum of young mice: model of aging and neurodegenerative disease. J Neurosci 1998;18:5614-5629.
43. Hoglinger GU, Rizk P, Muriel MP, et al. Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci 2004;7:726-735.
44. Marek K, Jennings D, Seibyl J. Do dopamine agonists or levodopa modify Parkinson's disease progression? Eur J Neurol 2002;9(suppl 3):15-22.
45. Stocchi F, Olanow CW. Neuroprotection in Parkinson's disease: clinical trials. Ann Neurol 2003;53(suppl 3):S87-S97.